Showing results (81-90 of 142) with videos related to

Sort By:
Pageof 15
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|August 23, 2013
Perivascular fibroblasts form the fibrotic scar after contusive spinal cord injuryCynthia Soderblom, Xueting Luo, Ezra Blumenthal, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 1, 2020
A Phase Ib Study of Onvansertib, a Novel Oral PLK1 Inhibitor, in Combination Therapy for Patients with Relapsed or Refractory Acute Myeloid LeukemiaAmer M Zeidan, Maya Ridinger, Tara L Lin, et al.
Blood Advances|December 21, 2021
Atezolizumab alone or in combination did not demonstrate a favorable risk-benefit profile in myelodysplastic syndromeAaron T Gerds, Bart L Scott, Peter Greenberg, et al.
Cancer Chemotherapy and Pharmacology|May 18, 2019
A phase 2 study to assess the pharmacokinetics and pharmacodynamics of CPX-351 and its effects on cardiac repolarization in patients with acute leukemiasTara L Lin, Laura F Newell, Robert K Stuart, et al.
Endoscopy|June 9, 2016
High-dose omeprazole infusion compared with scheduled second-look endoscopy for prevention of peptic ulcer rebleeding: a randomized controlled trialPhilip Wai Yan Chiu, Henry Kin Ming Joeng, Catherine Lai Yin Choi, et al.
BMC Cancer|June 3, 2014
The SystHERs registry: an observational cohort study of treatment patterns and outcomes in patients with human epidermal growth factor receptor 2-positive metastatic breast cancerDebu Tripathy, Hope S Rugo, Peter A Kaufman, et al.
Blood Neoplasia|September 11, 2025
V-FAST: a phase 1b master trial to investigate CPX-351 combined with targeted agents in adults with newly diagnosed AMLVinod A Pullarkat, Mark Levis, James McCloskey, et al.
Blood Advances|March 16, 2021
Older adults with newly diagnosed high-risk/secondary AML who achieved remission with CPX-351: phase 3 post hoc analysesTara L Lin, David A Rizzieri, Daniel H Ryan, et al.
JNCI Cancer Spectrum|July 19, 2023
Quantifying the impact of the COVID-19 pandemic on cancer center clinical trial operationsThomas J George, Tara L Lin, Tricia Adrales Bentz, et al.
Annals of Hematology|May 9, 2026
Impact of diagnosis-to-treatment interval on the outcome of patients with acute myeloid leukemiaSamah Nassereddine, Yuan Feng, Jordan Selep, et al.
Pageof 15